Clover Health Investments, Corp.
HealthcareNASDAQ:CLOV · NASDAQ Global Select
-$0.17 today
Vol 10.45M · Avg 6.71M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $173.3M |
| Short-term Investments | $4.3M |
| Receivables | $202.7M |
| Other Current | $67.8M |
| Total Current Assets | $448.0M |
| PP&E (Net) | $6.9M |
| Intangible Assets | $3.0M |
| Long-term Investments | $202.2M |
| Other Non-current | $37.6M |
| Total Non-current Assets | $249.7M |
| Total Assets | $697.7M |
Analysis
Selected assets total $697.7M for Latest. The largest visible component is Receivables at $202.7M, about 29.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78.3M -59.8% | $194.5M +67.1% | $116.4M +12.2% | $103.8M -65.4% | $300.0M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $17.0M -36.9% | $27.0M -77.5% | $119.8M -48.1% | $231.0M -26.7% | $315.3M | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $158.7M +71.1% | $92.8M +7.6% | $86.2M -48.5% | $167.5M +53.1% | $109.4M | $533.8M | $399.4M | -$1.7B |
| Inventory | $0 | $0 | $0 | $0 | $0 | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $53.8M +244.3% | $15.6M -82.9% | $91.1M -12.9% | $104.5M +693.1% | $13.2M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $307.9M -10.3% | $343.1M -19.8% | $428.0M -31.5% | $625.0M -16.9% | $752.5M | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $6.4M +20.3% | $5.3M +4.4% | $5.1M -48.0% | $9.8M +27.8% | $7.7M | $1.2B | $1.5B | $687.8M |
| Goodwill | $0 | $0 | $0 -100.0% | $11.7M | $0 | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $3.0M +0.0% | $3.0M +0.0% | $3.0M -63.8% | $8.3M +94.9% | $4.2M | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $187.1M -7.3% | $201.7M +66.7% | $121.0M -12.4% | $138.1M -21.5% | $175.9M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $36.7M +32.9% | $27.6M +102.5% | $13.6M -13.4% | $15.7M +50.8% | $10.4M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $233.2M -1.9% | $237.6M +66.5% | $142.7M -22.3% | $183.6M -7.4% | $198.3M | -$15.3B | $14.8B | $11.3B |
| Total Assets | $541.0M -6.8% | $580.7M +1.8% | $570.7M -29.4% | $808.6M -15.0% | $950.8M | $13.3B | $11.9B | $10.6B |
| Account Payables | $153.3M +343.4% | $34.6M -7.0% | $37.2M +14.6% | $32.4M +15.3% | $28.1M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $0 | $0 | $0 | $0 | $0 | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 | $0 | $0 | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 -100.0% | $3.1M | $0 -100.0% | $138.6M | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $55.6M +146.4% | $22.6M -63.1% | $61.1M -25.1% | $81.6M +807.5% | $9.0M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $208.8M -2.2% | $213.5M -18.2% | $261.1M -39.5% | $431.5M +15.8% | $372.6M | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $0 | $0 | $0 | $0 -100.0% | $19.9M | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $23.5M -10.0% | $26.1M +29.4% | $20.2M +24.5% | $16.2M +14.9% | $14.1M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $23.5M -10.0% | $26.1M +12.6% | $23.2M +14.5% | $20.2M -48.0% | $38.9M | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $232.3M -3.0% | $239.6M -15.7% | $284.3M -37.1% | $451.7M +9.8% | $411.5M | $14.7B | $3.7B | $9.6B |
| Common Stock | $52.0K +4.0% | $50.0K +2.0% | $49.0K +6.5% | $46.0K +0.0% | $46.0K | $651.4M | $517.0M | $382.6M |
| Retained Earnings | -$2.3B -3.9% | -$2.2B -2.0% | -$2.2B -11.0% | -$1.9B -20.4% | -$1.6B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $528.0K +133.3% | -$1.6M +33.2% | -$2.4M +74.7% | -$9.4M -384.7% | -$1.9M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 -100.0% | $3.9M | $1.4B | $337.8M | $931.4M |
| Total Equity | $308.7M -9.5% | $341.1M +19.1% | $286.4M -19.8% | $356.9M -33.8% | $539.3M | $9.1B | $7.7B | $3.3B |
| Total Debt | $0 | $0 -100.0% | $4.7M -20.4% | $5.9M -78.9% | $27.8M | $724.2M | $410.6M | $399.4M |
| Net Debt | -$78.3M +59.8% | -$194.5M -74.1% | -$111.7M -14.1% | -$97.9M +64.0% | -$272.1M | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Twist Bioscience Corporation
NASDAQ:TWST
$4.74B
10x Genomics, Inc.
NASDAQ:TXG
$3.66B
LifeStance Health Group, Inc.
NASDAQ:LFST
$3.30B
National HealthCare Corporation
AMEX:NHC
$3.09B
Guardian Pharmacy Services, Inc.
NYSE:GRDN
$2.73B
Structure Therapeutics Inc.
NASDAQ:GPCR
$2.47B
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
$1.46B
QuidelOrtho Corporation
NASDAQ:QDEL
$963.54M
Certara, Inc.
NASDAQ:CERT
$808.94M
BGM Group Ltd.
NASDAQ:BGM
$75.23M
SEC Filings
Recent regulatory filings
No filings found.
How much cash does CLOV have?
Clover Health Investments, Corp. (CLOV) reported $78.30M in cash and equivalents in fiscal 2025.
How much debt does CLOV carry?
Clover Health Investments, Corp. (CLOV) reported $0.00 of total debt, with net debt of -$78,301,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.